Bacterial vaginosis is associated with higher risk of female-to-male transmission of HIV

June 26, 2012 in HIV & AIDS

An investigation led by UCSF has found that the risk of female-to-male HIV transmission is increased three fold for women with bacterial vaginosis, a common disorder in which the normal balance of bacteria in the vagina is disrupted.

"Previous research has shown that bacterial vaginosis can increase a women's risk of becoming infected with HIV as much as sixty percent. Our study is the first to show that the risk of transmitting HIV is also elevated. Our findings point to the need for additional research to improve the diagnosis and treatment of bacterial vaginosis, which is extremely common in sub-Saharan Africa, the region of the globe with the highest burden of HIV," said the study's lead author, Craig R. Cohen, MD, MPH, professor of obstetrics, gynecology and at UCSF.

The study is being published in the June 26th issue of PLoS Medicine.

The new research assessed the association between bacterial vaginosis and female-to-male HIV transmission risk in a prospective study of 2,236 HIV positive women and their uninfected from seven African countries. After controlling for socio-demographic factors, sexual behavior, , sexually transmitted infections, pregnancy and levels of HIV in the blood of the women with HIV, bacterial vaginosis was associated with a significantly increased risk for female-to-male .

Bacterial vaginosis is a condition where the normal balance of microorganisms naturally found in the vagina is altered. This disruption of vaginal flora takes place when bacteria that are helpful are reduced and more are increased. Besides increasing the risk of becoming infected with HIV, bacterial vaginosis can increase the risk of acquiring other sexually transmitted infections and increase the risk of preterm delivery. In addition, HIV-infected women with this disorder may have higher levels and greater shedding of the virus from the cervix and vagina.

"We looked at the increased shedding of HIV in the genital tract, but that was not sufficient to explain the increased risk of female-to-male . It is also possible that bacterial vaginosis causes inflammation and that could be a factor. We don't really understand the relationship between vaginal flora and inflammation," said Cohen.

In addition, he said, "we think it's likely that the sharing of genital tract microbiota between women and men may be implicated as a cause of the transmission risk. The interrelationship of the sharing of flora remains poorly understood and is an important avenue for future research."

Notwithstanding the need for better understanding of the role of vaginal flora, the development of more therapeutics for bacterial vaginosis, including better drugs and probiotics, would be a significant boost to women's health in general, as well as help decrease HIV acquisition and risks, added Cohen.

Journal reference: PLoS Medicine search and more info website

Provided by University of California, San Francisco search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Integrating mental health care into HIV care

The integration of mental health interventions into HIV prevention and treatment platforms can reduce the opportunity costs of care and improve treatment outcomes, argues a new Policy Forum article published in this week's ...

HIV & AIDS created 5 hours ago | popularity not rated yet | comments 0

After a decade, global AIDS program looks ahead

(AP)—The decade-old law that transformed the battle against HIV and AIDS in developing countries is at a crossroads. The dream of future generations freed from the epidemic is running up against an era ...

HIV & AIDS created 18 hours ago | popularity not rated yet | comments 0

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

HIV & AIDS created May 19, 2013 | popularity 5 / 5 (1) | comments 0

AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

HIV & AIDS created May 18, 2013 | popularity 5 / 5 (2) | comments 0

Peer-referral programs can increase HIV-testing in emergency departments

Researchers at the University of Cincinnati (UC) have found that incorporating a peer-referral program for HIV testing into emergency departments can reach new groups of high-risk patients and brings more patients into the ...

HIV & AIDS created May 17, 2013 | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.